论著

腹腔感染棘球蚴微囊对小鼠肝脏多房棘球蚴感染及致病的影响

  • 郭刚 ,
  • 任远 ,
  • 焦红杰 ,
  • 武娟 ,
  • 郭宝平 ,
  • 齐文静 ,
  • 李军 ,
  • 张文宝
展开
  • 1 省部共建中亚高发病成因与防治国家重点实验室,新疆医科大学第一附属医院临床医学研究院,乌鲁木齐 830054
    2 苏州市疾病预防控制中心,江苏苏州 215003
    3 新疆医科大学儿科学院,乌鲁木齐 830054
    4 新疆医科大学基础医学院,乌鲁木齐 830017
郭刚(1978-),男,博士,副主任医师,从事传染病防控研究。E-mail:guog@foxmail.com
*张文宝(1962-),男,博士,研究员,从事人兽共患病的防治。E-mail:wenbaozhang2013@163.com

收稿日期: 2022-07-11

  修回日期: 2022-11-19

  网络出版日期: 2023-05-10

基金资助

国家自然科学基金(31860703);国家自然科学基金(81830066);省部共建中亚高发病成因与防治国家重点实验室开放课题(SKL-HIDCA-2019-27)

Effect of intraperitoneal inoculation with Echinococcus microcysts on the infection and pathogenicity of E. multilocularis in mouse liver

  • GUO Gang ,
  • REN Yuan ,
  • JIAO Hongjie ,
  • WU Juan ,
  • GUO Baoping ,
  • QI Wenjing ,
  • LI Jun ,
  • ZHANG Wenbao
Expand
  • 1 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    2 Suzhou Center For Disease Prevention and Control, Suzhou 215003, Jiangsu, China
    3 Academy of Pediatrics, Xinjiang Medical University, Urumqi 830054, China
    4 School of basic medicine, Xinjiang Medical University, Urumqi 830017, China

Received date: 2022-07-11

  Revised date: 2022-11-19

  Online published: 2023-05-10

Supported by

National Natural Science Foundation of China(31860703);National Natural Science Foundation of China(81830066);project of State Key Laboratory of Pathogenesis and Prevention of Middle Asian High Disease(SKL-HIDCA-2019-27)

摘要

目的 探讨腹腔感染细粒棘球蚴(Eg)或多房棘球蚴(Em)微囊对小鼠肝脏Em感染及致病的影响。方法 收集Eg和Em原头节,分别体外成囊培养6周和8周。将60只C57雌性小鼠随机分为Em/Em感染组、Eg/Em感染组、单纯Em肝脏感染组和假手术组等4组,每组15只。Em/Em感染组、Eg/Em感染组、单纯Em肝脏感染组小鼠分别腹腔注射感染Em微囊50个(1 × PBS缓冲液稀释至1 ml)、Eg微囊50个(1 × PBS缓冲液稀释至1 ml)、生理盐水1 ml,1个月后小鼠开腹,经肝门静脉注射感染2 000个(200 µl)Em原头节;假手术组小鼠腹腔和肝门静脉注射等量生理盐水。小鼠腹腔感染前及感染后第1、3和6个月尾静脉采血,ELISA检测血清中抗包囊囊液蛋白抗体情况。肝门静脉感染后1、3和6个月,每组各剖检5只小鼠,肉眼观察肝脏病灶感染情况,并进行量化计分。取各组小鼠大叶肝脏,进行石蜡切片和HE染色,观察肝脏病灶组织情况。采用SPSS 21.0进行统计学分析,数据采用独立样本t检验。结果 体外培养6周的Eg微囊直径为300~500 µm,培养8周的Em微囊直径为150~300 µm。ELISA结果显示,腹腔感染棘球蚴微囊后1、3、6个月,Em/Em感染组和Eg/Em感染组小鼠血清中抗包囊囊液蛋白抗体水平(A405值)均上升且维持较高水平,其中感染后1个月的A405值分别为2.77 ± 0.62、2.35 ± 0.23,较假手术组的0.15 ± 0.02升高10倍以上。肝门静脉感染1、3和6个月后剖检,Eg/Em感染组腹腔可见Eg包囊形成,Em/Em感染组、单纯Em肝脏感染组和假手术组则均未见有包囊形成。肝门静脉感染后1、3、6个月,单纯Em肝脏感染组小鼠的肝脏病灶最为严重,肝脏表面大多有数十个点状或大小不一泡状病灶;Eg/Em感染组小鼠肝脏病灶较弱或正常,肝脏表面有1~3个微小病灶,且随感染周期延长趋于正常。Em/Em组和假手术组小鼠肝脏在不同时期均未见病灶。病灶严重程度评分结果显示,单纯Em肝脏感染组各时期评分(4.8 ± 1.3、5.0 ± 1.5、4.5 ± 1.4)均高于Eg/Em感染组(1.6 ± 0.9、1.2 ± 1.1、1.6 ± 0.9)(t = 4.92、4.81、5.24,均P < 0.01)。HE染色结果显示,肝门静脉感染Em原头节后1个月,单纯Em肝脏感染组病灶有大量炎性细胞浸润,以嗜酸粒细胞为主;Eg/Em感染组病灶的炎性细胞浸润较少;感染后3个月,单纯Em肝脏感染组病灶的炎性细胞相对前期减少,以中性粒细胞居多,病灶周边形成胶原纤维层;Eg/Em感染组病灶以胶原纤维层为主;感染后6个月,Eg/Em感染组病灶恢复正常趋势较明显,以结缔组织增生为主。结论 腹腔Em感染可完全阻断小鼠肝脏Em再感染,腹腔Eg感染可较大程度抑制小鼠肝脏Em感染。

本文引用格式

郭刚 , 任远 , 焦红杰 , 武娟 , 郭宝平 , 齐文静 , 李军 , 张文宝 . 腹腔感染棘球蚴微囊对小鼠肝脏多房棘球蚴感染及致病的影响[J]. 中国寄生虫学与寄生虫病杂志, 2023 , 41(2) : 156 -162 . DOI: 10.12140/j.issn.1000-7423.2023.02.005

Abstract

Objective To investigate the effect of intraperitoneal inoculation of Echinococcus granulosus (Eg) or E. multilocularis (Em) micorcysts on hepatic infection and pathogenesis of Em in mice liver. Methods The protoscoleces (PSCs) of Eg and Em were collected and cultured in vitro for 6 and 8 weeks to encyst, respectively. Sixty C57 female mice were randomly assigned to 4 groups, which were Em/Em infection, Em/Eg infection, pure Em infection and sham surgery groups, with 15 mice in each group. The mice of designated infection groups were intraperitoneally injected with 50 Em microcysts (diluted in 1 ml 1 × PBS), the mice in the Eg/Em infection group were intraperitoneally inoculated with 50 Eg microcysts, and 1 ml of normal saline, respectively. After 1 month, the mice in all three groups underwent laparotomy and were injected with 2 000 Em PSCs (200 µl) through hepatic portal vein (HPV). The mice in the sham operation group were injected with the same amount of normal saline into HPV in abdominal cavity. Mice blood was collected from the tail vein before intraperitoneal inoculation and at 1, 3 and 6 months after inoculation. In the collected blood samples, serum antibodies against hydatid cyst fluid antigen were detected by ELISA. At 1, 3 and 6 months after HPV infection, 5 mice in each group were dissected to inspect the liver lesions of infection with naked eyes and conduct quantitative scoring. The big lobe of liver was collected from mice to prepare paraffin section, and stain with HE to observe the changes in liver lesion tissue. SPSS 21.0 was used for statistical analysis, and an independent sample t-test was used to compare the mean between the two groups. Results The diameter of Eg microcysts cultured for 6 weeks in vitro is about 300 to 500 µm, and the diameter of Em microcysts cultured for 8 weeks is about 150 to 300 µm. ELISA results showed that after 1, 3, and 6 months of intraperitoneal infection with echinococcus microcapsules, the levels of anti-cyst fluid protein antibodies (A405 values) in the serum of mice infected with Em/Em and Eg/Em elevated and maintained at high level. One month after intraperitoneal inoculation of microcysts, the serum anti cyst fluid protein antibody levels (A405 values) in mice infected with Em/Em and Eg/Em groups were 2.77 ± 0.62 and 2.35 ± 0.23, respectively, which were more than 10 times higher than 0.15 ± 0.02 in the sham operation group. After 1, 3, and 6 months of HPV infection, the autopsy was performed. Eg cysts were seen in the abdominal cavity of the Eg/Em infected group, while no cysts were seen in the Em/Em group, the Em liver infected group and the sham group. Liver infection at different stages was the most severe in the Em liver infection group, where the liver surface was mostly covered with punctate or vesicular lesions of varying sizes. In the Eg/Em infection group, the infected lesions were weak or normal, and there were 1-3 small lesions on the liver surface that tend to become normal as the infection cycle extends. No infectious lesions were found in the Em/Em group and the sham group at different stages. The results of the lesion severity score showed that the scores of each stage in the group with Em liver infection (4.8 ± 1.3, 5.0 ± 1.5, 4.5 ± 1.4) were higher than those in the group with Eg/Em infection (1.6 ± 0.9, 1.2 ± 1.1, 1.6 ± 0.9) (t = 4.92, 4.81, 5.24, all P < 0.01). The results of HE staining showed that 1 month after HPV infection with Em PSCs, there was a large number of inflammatory cells infiltrating the lesions in the Em liver infection group, mainly eosinophils; In the Eg/Em infected group, there was less infiltration of inflammatory cells in the lesion. At 3 months after infection, the inflammatory cells in the focus of the simple Em liver infection group decreased relative to the prophase, with neutrophils predominating, and a collagen fibre layer formed around the focus; In the Eg/Em infection group, the focus was mainly collagen fibre layer; At 6 months after infection, the lesions in both the Em liver infection group and the Eg/Em infection group showed a trend of recovery, mainly with connective tissue hyperplasia. Conclusion Em microcysts infection via abdominal cavity can completely block Em reinfection in mice liver, and Eg infection via abdominal cavity can suppress Em infection in mice liver to a greater extent.

参考文献

[1] Han S, Kui Y, Xue CZ, et al. The endemic status of echinococcosis in China from 2004 to 2020[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 475-480. (in Chinese)
  (韩帅, 蒉嫣, 薛垂召, 等. 2004—2020年全国棘球蚴病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 475-480.)
[2] Zheng CJ, Yang L, Zhang GJ, et al. Interpretation of technical scheme for echinococcosis control (edition 2019)[J]. J Trop Dis Parasitol, 2020, 18(4): 193-196, 201. (in Chinese)
  (郑灿军, 杨柳, 张光葭, 等. 《包虫病防治技术方案(2019年版)》解读[J]. 热带病与寄生虫学, 2020, 18(4):193- 196, 201.)
[3] Pohnan R, Ryska M, Hytych V, et al. Echinococcosis mimicking liver malignancy: a case report[J]. Int J Surg Case Rep, 2017, 36: 55-58.
[4] Siles-Lucas M, Casulli A, Cirilli R, et al. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets[J]. PLoS Negl Trop Dis, 2018, 12(4): e0006422.
[5] Yang C, He JY, Yang XW, et al. Surgical approaches for definitive treatment of hepatic alveolar echinococcosis: results of a survey in 178 patients[J]. Parasitology, 2019, 146(11): 1414-1420.
[6] Larrieu E, Herrero E, Mujica G, et al. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary data[J]. Acta Trop, 2013, 127(2): 143-151.
[7] Zhang WB, Li J, You H, et al. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere[J]. Am J Trop Med Hyg, 2003, 68(1): 40-43.
[8] Bowles J, Blair D, McManus DP. Genetic variants within the genus Echinococcus identified by mitochondrial DNA sequencing[J]. Mol Biochem Parasitol, 1992, 54(2): 165-173.
[9] Nakao M, Xiao N, Okamoto M, et al. Geographic pattern of genetic variation in the fox tapeworm Echinococcus multilocularis[J]. Parasitol Int, 2009, 58(4): 384-389.
[10] Alvarez Rojas CA, Kronenberg PA, Aitbaev S, et al. Genetic diversity of Echinococcus multilocularis and Echinococcus granulosus sensu lato in Kyrgyzstan: the A2 haplotype of E. multilocularis is the predominant variant infecting humans[J]. PLoS Negl Trop Dis, 2020, 14(5): e0008242.
[11] Shang JY, Zhang GJ, Yu WJ, et al. Genetic polymorphism of Echinococcus multilocularis in northwestern China inferred from cox1 gene sequences[J]. J Pathog Biol, 2021, 16(2): 137-142. (in Chinese)
  (尚婧晔, 张光葭, 喻文杰, 等. 中国西北部地区多房棘球绦虫cox1基因多态性研究[J]. 中国病原生物学杂志, 2021, 16(2): 137-142.)
[12] Konyaev SV, Yanagida T, Ingovatova GM, et al. Molecular identification of human echinococcosis in the Altai region of Russia[J]. Parasitol Int, 2012, 61(4): 711-714.
[13] Laurim?e T, Kronenberg PA, Alvarez Rojas CA, et al. Long-term (35 years) cryopreservation of Echinococcus multilocularis metacestodes[J]. Parasitology, 2020, 147(9): 1048-1054.
[14] Liu HD, Wang HB, Fan HN, et al. Alveolar echinococcosis and immune evasion[J]. Chin J Parasitol Parasit Dis, 2018, 36(6): 655-660. (in Chinese)
  (刘寒冬, 王宏宾, 樊海宁, 等. 多房棘球蚴病的免疫逃避机制[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 655-660.)
[15] Zhang LH, Chen G, Chong SG, et al. Research progress on the immune regulation mechanism in alveolar echinococcosis[J]. Chin J Parasitol Parasit Dis, 2022, 40(1): 109-113, 120. (in Chinese)
  (张伶慧, 陈根, 种世桂, 等. 多房棘球蚴病中免疫细胞调控机制的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(1): 109-113, 120.)
[16] Zheng HJ, Zhang WB, Zhang L, et al. The genome of the hydatid tapeworm Echinococcus granulosus[J]. Nat Genet, 2013, 45(10): 1168-1175.
[17] Tsai IJ, Zarowiecki M, Holroyd N, et al. The genomes of four tapeworm species reveal adaptations to parasitism[J]. Nature, 2013, 496(7443): 57-63.
[18] Guo BP. Study on correlation between pathogenic differences and mitochondrial genetic markers in Echinococcus multilocularis[D]. Shihezi: Shihezi University, 2019: 29-97. (in Chinese)
  (郭宝平. 多房棘球绦虫致病差异与线粒体遗传标志相关性的研究[D]. 石河子: 石河子大学, 2019: 29-97.)
[19] Shang JY, Zhang GJ, Yu WJ, et al. Advances in researches on the genetic diversity of Echinococcus multilocularis[J]. Chin J Parasitol Parasit Dis, 2020, 38(5): 637-641, 646. (in Chinese)
  (尚婧晔, 张光葭, 喻文杰, 等. 多房棘球绦虫遗传多态性研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(5): 637-641, 646.)
[20] Yin J. Clinical characteristics of patients with hepatic alveolar hydatid and cystic echinococcosis mixed infection[D]. Xining: Qinghai University, 2019: 36-44. (in Chinese)
  (尹杰. 肝泡型合并囊型包虫混合感染患者的临床特点分析[D]. 西宁: 青海大学, 2019: 36-44.)
文章导航

/

〈 〉